Jason Wasfy, MD, associate professor at the Harvard Medical School and director of quality and outcomes research, Massachusetts General Hospital Heart Center, spoke at the Heart Rhythm Society 2024 meeting in the business of cardiology sessions about the current and future models of value based payments.

Value-based care gives cardiology practices an opportunity to thrive

Value-based payments can impact cardiology practices in many ways, helping cardiologists acquire new technology and boost patient care.

Thomas Maddox, MD, explains some of the new, innovative technologies people should watch for in cardiology. He said some of these may define how cardiologist practice medicine in the next couple years.

Remote monitoring, AI to play key roles in the future of cardiology

Serious changes could be coming to a cardiology practice near you.

healthcare business deal

Tracking private equity: Cardiologist, CEO share perspective on acquisition trends

The ongoing rise of private equity continues to be one of the biggest topics in modern healthcare. 

ASE President Ted Abraham, MD, speaking at the ASE HCM forum in 2023. Photo by Dave Fornell

Cardiologist begins term as American Society of Echocardiography's new president

Cardiologist Theodore Abraham, MD, has been an ASE member for more than two decades. He is now the organization's 2024-2025 president. 

Mediterranean diet may protect the hearts of cancer survivors

The popular diet prioritizes whole grains, fruits, vegetables, legumes, nuts, seeds and olive oil. Researchers found that it was associated with multiple long-term benefits for patients with a cancer diagnosis. 

merger acquisition M&A business

Private equity in cardiology: 4 key takeaways from a 10-year analysis

Tracking private equity acquisitions can be challenging, but that didn't stop researchers from exploring the last decade of activity in cardiology. "It will be critical to monitor the effects on procedural utilization, quality and outcomes for patients with CVD,” the group wrote. 

Biolimus A9 Coated Balloon from BioAscend

In-stent restenosis after PCI: New biolimus-coated balloon non-inferior to paclitaxel devices

A new study of nearly 300 PCI patients suggests biolimus-coated balloons could provide significant value to interventional cardiologists in the years ahead.  

Denise Busman from MedAxoim explains importance of the business management model in cardiology departments. She presented in a business of cardiology session at ACC 2024. #Medaxoim #ACC #ACC2024

Why your cardiology department's leadership structure matters

The way a cardiology department's management is organized can have a direct impact on physician satisfaction and patient care. "Without good governance and leadership, nothing else matters," one expert said.